Allergy, Asthma & Clinical Immunology

Table 12 Patient gender and age

From: Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network

	2021			2018			2013
	US	INT’L	Global	US	INT’L	Global	Global	% change (%)
Gender
Male	7334	28,627	35,961	6085	19,790	25,875	3540	915.8
Female	5695	20,389	26,084	4763	13,944	18,707	2803	830.6
Total	13,029	49,016	62,045	10,848	33,734	44,582	6343	878.2
Age
< 1 year	958	3148	4106	672	2211	2883	149	2655.7
1–4 years	2712	7641	10,353	1797	4987	6784
5–19 years	5196	16,431	21,627	3894	11,366	15,260
Total pediatric	8866	27,220	36,086	6363	18,564	24,927
20–39 years	1769	7161	8930	2042	5855	7897
> 40 years	3287	7884	11,171	2092	4111	6203
Total adult	5056	15,045	20,101	4134	9966	14,100
Grand total	13,922	42,265	56,187	10,497	28,530	39,027	5993	837.5

The number of patients by age and gender in the United States and internationally in 2021, 2018, and 2013

Back to article page

ISSN: 1710-1492

Contact us

Submission enquiries: shanmathi.ethiraj@springernature.com
General enquiries: info@biomedcentral.com